Chapter/Section Purchase

1 Biomaterial Implants Market Overview
1.1 Product Overview and Scope of Biomaterial Implants
1.2 Biomaterial Implants Segment by Type
1.2.1 Global Biomaterial Implants Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Cardiovascular Implants
1.2.3 Orthopedic Implants
1.2.4 Dental Implants
1.2.5 Other Soft Tissue Implants
1.3 Biomaterial Implants Segment by Application
1.3.1 Global Biomaterial Implants Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Beauty Institutions
1.4 Global Biomaterial Implants Market Size Estimates and Forecasts
1.4.1 Global Biomaterial Implants Revenue 2017-2028
1.4.2 Global Biomaterial Implants Sales 2017-2028
1.4.3 Biomaterial Implants Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biomaterial Implants Market Competition by Manufacturers
2.1 Global Biomaterial Implants Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biomaterial Implants Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biomaterial Implants Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biomaterial Implants Manufacturing Sites, Area Served, Product Type
2.5 Biomaterial Implants Market Competitive Situation and Trends
2.5.1 Biomaterial Implants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biomaterial Implants Players Market Share by Revenue
2.5.3 Global Biomaterial Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biomaterial Implants Retrospective Market Scenario by Region
3.1 Global Biomaterial Implants Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biomaterial Implants Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biomaterial Implants Market Facts & Figures by Country
3.3.1 North America Biomaterial Implants Sales by Country
3.3.2 North America Biomaterial Implants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biomaterial Implants Market Facts & Figures by Country
3.4.1 Europe Biomaterial Implants Sales by Country
3.4.2 Europe Biomaterial Implants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biomaterial Implants Market Facts & Figures by Region
3.5.1 Asia Pacific Biomaterial Implants Sales by Region
3.5.2 Asia Pacific Biomaterial Implants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biomaterial Implants Market Facts & Figures by Country
3.6.1 Latin America Biomaterial Implants Sales by Country
3.6.2 Latin America Biomaterial Implants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biomaterial Implants Market Facts & Figures by Country
3.7.1 Middle East and Africa Biomaterial Implants Sales by Country
3.7.2 Middle East and Africa Biomaterial Implants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biomaterial Implants Historic Market Analysis by Type
4.1 Global Biomaterial Implants Sales Market Share by Type (2017-2022)
4.2 Global Biomaterial Implants Revenue Market Share by Type (2017-2022)
4.3 Global Biomaterial Implants Price by Type (2017-2022)
5 Global Biomaterial Implants Historic Market Analysis by Application
5.1 Global Biomaterial Implants Sales Market Share by Application (2017-2022)
5.2 Global Biomaterial Implants Revenue Market Share by Application (2017-2022)
5.3 Global Biomaterial Implants Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Integra LifeSciences
6.1.1 Integra LifeSciences Corporation Information
6.1.2 Integra LifeSciences Description and Business Overview
6.1.3 Integra LifeSciences Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Integra LifeSciences Biomaterial Implants Product Portfolio
6.1.5 Integra LifeSciences Recent Developments/Updates
6.2 NuVasive
6.2.1 NuVasive Corporation Information
6.2.2 NuVasive Description and Business Overview
6.2.3 NuVasive Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.2.4 NuVasive Biomaterial Implants Product Portfolio
6.2.5 NuVasive Recent Developments/Updates
6.3 Edward LifeSciences
6.3.1 Edward LifeSciences Corporation Information
6.3.2 Edward LifeSciences Description and Business Overview
6.3.3 Edward LifeSciences Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Edward LifeSciences Biomaterial Implants Product Portfolio
6.3.5 Edward LifeSciences Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Corporation Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Stryker Biomaterial Implants Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 LifeCell
6.5.1 LifeCell Corporation Information
6.5.2 LifeCell Description and Business Overview
6.5.3 LifeCell Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.5.4 LifeCell Biomaterial Implants Product Portfolio
6.5.5 LifeCell Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Medtronic Biomaterial Implants Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 RTI Surgical
6.6.1 RTI Surgical Corporation Information
6.6.2 RTI Surgical Description and Business Overview
6.6.3 RTI Surgical Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.4.4 RTI Surgical Biomaterial Implants Product Portfolio
6.7.5 RTI Surgical Recent Developments/Updates
6.8 BioPolymer
6.8.1 BioPolymer Corporation Information
6.8.2 BioPolymer Description and Business Overview
6.8.3 BioPolymer Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.8.4 BioPolymer Biomaterial Implants Product Portfolio
6.8.5 BioPolymer Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Johnson & Johnson Biomaterial Implants Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Baxter International
6.10.1 Baxter International Corporation Information
6.10.2 Baxter International Description and Business Overview
6.10.3 Baxter International Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Baxter International Biomaterial Implants Product Portfolio
6.10.5 Baxter International Recent Developments/Updates
6.11 Vericel
6.11.1 Vericel Corporation Information
6.11.2 Vericel Biomaterial Implants Description and Business Overview
6.11.3 Vericel Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Vericel Biomaterial Implants Product Portfolio
6.11.5 Vericel Recent Developments/Updates
6.12 Alphatec Spine
6.12.1 Alphatec Spine Corporation Information
6.12.2 Alphatec Spine Biomaterial Implants Description and Business Overview
6.12.3 Alphatec Spine Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Alphatec Spine Biomaterial Implants Product Portfolio
6.12.5 Alphatec Spine Recent Developments/Updates
6.13 CryoLife
6.13.1 CryoLife Corporation Information
6.13.2 CryoLife Biomaterial Implants Description and Business Overview
6.13.3 CryoLife Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.13.4 CryoLife Biomaterial Implants Product Portfolio
6.13.5 CryoLife Recent Developments/Updates
6.14 Maxigen Biotech
6.14.1 Maxigen Biotech Corporation Information
6.14.2 Maxigen Biotech Biomaterial Implants Description and Business Overview
6.14.3 Maxigen Biotech Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Maxigen Biotech Biomaterial Implants Product Portfolio
6.14.5 Maxigen Biotech Recent Developments/Updates
6.15 IOP Ophthalmic Products
6.15.1 IOP Ophthalmic Products Corporation Information
6.15.2 IOP Ophthalmic Products Biomaterial Implants Description and Business Overview
6.15.3 IOP Ophthalmic Products Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.15.4 IOP Ophthalmic Products Biomaterial Implants Product Portfolio
6.15.5 IOP Ophthalmic Products Recent Developments/Updates
6.16 CONMED
6.16.1 CONMED Corporation Information
6.16.2 CONMED Biomaterial Implants Description and Business Overview
6.16.3 CONMED Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.16.4 CONMED Biomaterial Implants Product Portfolio
6.16.5 CONMED Recent Developments/Updates
6.17 Allergan
6.17.1 Allergan Corporation Information
6.17.2 Allergan Biomaterial Implants Description and Business Overview
6.17.3 Allergan Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Allergan Biomaterial Implants Product Portfolio
6.17.5 Allergan Recent Developments/Updates
6.18 BioTissue
6.18.1 BioTissue Corporation Information
6.18.2 BioTissue Biomaterial Implants Description and Business Overview
6.18.3 BioTissue Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.18.4 BioTissue Biomaterial Implants Product Portfolio
6.18.5 BioTissue Recent Developments/Updates
6.19 Auto Tissue Berlin
6.19.1 Auto Tissue Berlin Corporation Information
6.19.2 Auto Tissue Berlin Biomaterial Implants Description and Business Overview
6.19.3 Auto Tissue Berlin Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Auto Tissue Berlin Biomaterial Implants Product Portfolio
6.19.5 Auto Tissue Berlin Recent Developments/Updates
6.20 MiMedx Group
6.20.1 MiMedx Group Corporation Information
6.20.2 MiMedx Group Biomaterial Implants Description and Business Overview
6.20.3 MiMedx Group Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.20.4 MiMedx Group Biomaterial Implants Product Portfolio
6.20.5 MiMedx Group Recent Developments/Updates
6.21 Organogenesis
6.21.1 Organogenesis Corporation Information
6.21.2 Organogenesis Biomaterial Implants Description and Business Overview
6.21.3 Organogenesis Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Organogenesis Biomaterial Implants Product Portfolio
6.21.5 Organogenesis Recent Developments/Updates
6.22 Osiris Therapeutics
6.22.1 Osiris Therapeutics Corporation Information
6.22.2 Osiris Therapeutics Biomaterial Implants Description and Business Overview
6.22.3 Osiris Therapeutics Biomaterial Implants Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Osiris Therapeutics Biomaterial Implants Product Portfolio
6.22.5 Osiris Therapeutics Recent Developments/Updates
7 Biomaterial Implants Manufacturing Cost Analysis
7.1 Biomaterial Implants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biomaterial Implants
7.4 Biomaterial Implants Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biomaterial Implants Distributors List
8.3 Biomaterial Implants Customers
9 Biomaterial Implants Market Dynamics
9.1 Biomaterial Implants Industry Trends
9.2 Biomaterial Implants Market Drivers
9.3 Biomaterial Implants Market Challenges
9.4 Biomaterial Implants Market Restraints
10 Global Market Forecast
10.1 Biomaterial Implants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biomaterial Implants by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biomaterial Implants by Type (2023-2028)
10.2 Biomaterial Implants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biomaterial Implants by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biomaterial Implants by Application (2023-2028)
10.3 Biomaterial Implants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biomaterial Implants by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biomaterial Implants by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer